| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥41.8B | ¥40.4B | +3.6% |
| Operating Income | ¥-1.6B | ¥-1.0B | -58.2% |
| Ordinary Income | ¥-1.6B | ¥-0.8B | -95.1% |
| Net Income | ¥-1.6B | ¥-1.2B | -34.5% |
| ROE | -3.7% | -2.7% | - |
FY2026 Q3 cumulative results: Revenue 41.8B yen (YoY +3.6%), Operating Loss -1.6B yen (prior year loss -1.0B yen, deterioration -58.2%), Ordinary Loss -1.6B yen (YoY -95.1%), Net Loss -1.6B yen (YoY -34.5%). The company achieved modest top-line growth but profitability deteriorated across all levels. Operating margin contracted to -3.9% from -2.5% in the prior year as SG&A expenses of 9.9B yen exceeded gross profit of 8.2B yen despite maintaining a gross margin of 19.7%. While operating cash flow improved significantly to 3.2B yen (YoY +112.2%) and free cash flow remained positive at 1.8B yen, the operating CF to net income ratio of -1.96x indicates earnings quality concerns. The company faces elevated financial leverage with net debt to EBITDA of 11.6x and negative interest coverage, though short-term liquidity remains adequate with a current ratio of 232.4% and cash coverage of short-term debt at 4.65x.
Revenue increased 1.4B yen or 3.6% YoY to 41.8B yen, driven by demand in the crystal products business. However, cost of sales increased proportionally to 33.6B yen, maintaining gross profit at 8.2B yen with a stable gross margin of 19.7% compared to prior year. The primary drag on profitability came from SG&A expenses of 9.9B yen representing 23.6% of revenue, an increase from 23.1% in the prior year, creating structural pressure that pushed operating income deeper into loss territory at -1.6B yen versus -1.0B yen prior year. Non-operating items contributed minimal net impact with non-operating income of 0.5B yen (primarily interest income 0.3B yen and FX gains 0.1B yen) largely offset by non-operating expenses of 0.5B yen (interest expense 0.4B yen), resulting in ordinary loss of -1.6B yen. Extraordinary items showed significant activity with gain on asset sales of 2.1B yen partially offset by extraordinary losses of 1.3B yen, creating a net extraordinary gain of 0.8B yen. The gap between ordinary loss of -1.6B yen and pretax loss of -0.9B yen reflects this 0.8B yen non-recurring benefit. Tax expense of 0.7B yen appears counterintuitive against a pretax loss, indicating deferred tax adjustments or non-deductible items, ultimately resulting in net loss of -1.6B yen. Despite depreciation of 4.6B yen providing a non-cash buffer, EBITDA of 3.0B yen translates to a 7.1% EBITDA margin, insufficient to cover interest expense of 0.4B yen and maintain positive bottom-line profitability. This represents a revenue up/profit down pattern where modest sales growth failed to translate into operating leverage due to fixed cost burden and SG&A escalation.
[Profitability] ROE of -3.7% deteriorated from prior year positive territory due to net losses, operating margin of -3.9% worsened from -2.5% prior year as SG&A expenses outpaced gross profit generation. EBITDA margin of 7.1% provides some cash earnings cushion though insufficient to achieve bottom-line profitability. [Cash Quality] Cash and deposits of 30.0B yen provide short-term debt coverage of 4.65x against short-term borrowings of 6.5B yen. Operating cash flow of 3.2B yen represents -1.96x of net income, indicating cash generation diverges from accounting losses due to non-cash items and working capital dynamics. Free cash flow of 1.8B yen remains positive, supporting liquidity despite negative earnings. [Investment Efficiency] Asset turnover of 0.40x falls below manufacturing industry median of 0.56x, indicating underutilization of asset base. CapEx to depreciation ratio of 0.59x suggests potential underinvestment relative to asset replacement needs. Inventory turnover of 219 days (DIO) significantly exceeds industry median of 112 days, highlighting working capital inefficiency. Receivables turnover of 99 days (DSO) also exceeds industry median of 85 days. Cash conversion cycle of 290 days reflects extended working capital requirements. [Financial Health] Equity ratio of 41.4% sits below industry median of 63.8%, indicating higher leverage. Current ratio of 232.4% substantially exceeds industry median of 287%, providing adequate short-term liquidity buffer. Total interest-bearing debt of 34.1B yen (short-term 6.5B yen, long-term 27.6B yen) against EBITDA of 3.0B yen produces net debt to EBITDA ratio of 11.6x, well above investment grade thresholds. Interest coverage is negative at -3.74x as operating income fails to cover interest expense of 0.4B yen, presenting a significant solvency warning signal.
Operating cash flow of 3.2B yen increased 112.2% YoY, representing -1.96x of net loss of -1.6B yen, with the positive operating CF driven by depreciation and amortization of 4.6B yen and favorable working capital movements. Specifically, decrease in receivables contributed 1.0B yen inflow while inventory increase absorbed 1.4B yen, with payables increasing 0.2B yen. Operating CF subtotal before working capital changes was 3.5B yen, indicating core cash generation capability despite accounting losses. Investing cash flow of -1.4B yen primarily reflected CapEx of -2.7B yen, though CapEx to depreciation ratio of 0.59x suggests investment below maintenance levels and potential future capacity constraints. Free cash flow of 1.8B yen (operating CF 3.2B yen plus investing CF -1.4B yen) remained positive and sufficient to cover forecasted annual dividends of approximately 0.4B yen based on 5 yen per share. Financing cash flow of -0.8B yen included minimal share repurchases of 0.0B yen. Interest paid of 0.4B yen and interest received of 0.3B yen resulted in net interest cash outflow of 0.1B yen. Income taxes paid of 0.3B yen were modest relative to operating scale. Short-term borrowings increased 2.5B yen or 61% YoY from 4.0B yen to 6.5B yen, indicating shift toward shorter maturity debt structure and potential refinancing of maturing long-term debt, which warrants monitoring of debt maturity profile and rollover risk given elevated leverage metrics.
Ordinary loss of -1.6B yen versus operating loss of -1.6B yen shows minimal non-operating contribution, with non-operating income of 0.5B yen approximately offsetting non-operating expenses of 0.5B yen. Non-operating income composition includes interest income of 0.3B yen, FX gains of 0.1B yen, and other income of 0.1B yen, representing 1.2% of revenue and reflecting primarily financial management activities rather than core operations. Interest expense of 0.4B yen creates a net financial cost burden when combined with interest income. Pretax loss of -0.9B yen improved from ordinary loss of -1.6B yen due to extraordinary gain of 0.8B yen net (extraordinary income 2.1B yen including asset sales minus extraordinary losses 1.3B yen), flagging significant non-recurring items that artificially reduced reported net loss. Tax expense of 0.7B yen against a pretax loss produces an effective tax rate of -85.9%, indicating deferred tax asset valuation adjustments or other non-cash tax items that further distort accounting earnings. Operating cash flow of 3.2B yen substantially exceeds net loss of -1.6B yen in absolute terms, with the divergence attributable to depreciation of 4.6B yen (non-cash expense), working capital improvements in receivables of 1.0B yen, partially offset by inventory build of -1.4B yen, and the reversal of non-cash tax charges. This operating CF to net income ratio of -1.96x indicates earnings quality concerns as cash generation relies heavily on non-cash add-backs and one-time working capital timing rather than sustainable operating profitability, though the positive cash generation itself provides near-term financial flexibility.
Full-year guidance calls for revenue of 57.4B yen (YoY +0.7%), operating loss of -2.2B yen, ordinary loss of -2.4B yen, and EPS of -32.42 yen with no forecast revision this quarter. Q3 cumulative results show revenue progress of 72.8% (41.8B yen of 57.4B yen target), which is below the standard 75% benchmark for Q3, indicating potential fourth quarter acceleration or risk of slight revenue shortfall. Operating loss of -1.6B yen cumulative represents 74.5% of full-year loss guidance of -2.2B yen, suggesting Q4 loss forecast of approximately -0.6B yen. This implies sequential improvement from Q1-Q3 run rate but continued negative profitability through year-end. Given the asset sales and extraordinary items recorded in Q3, the company appears to be executing asset optimization measures to manage cash position. Forecast assumptions from forecast notes indicate performance subject to market conditions and information available at reporting date, with actual results potentially varying materially. The company maintained dividend forecast at 5 yen despite negative earnings guidance, indicating management commitment to shareholder returns supported by positive free cash flow. Progress rate analysis suggests Q4 revenue must reach approximately 15.6B yen to achieve full-year target, representing modest acceleration from Q3 quarterly average of 13.9B yen, which appears achievable absent demand shocks. Operating loss trajectory requires Q4 improvement to contain loss within -0.6B yen, necessitating either revenue leverage or cost containment actions in the final quarter.
Annual dividend forecast of 5.00 yen per share remains unchanged from prior year, with no dividend revision announced this quarter. Based on forecasted EPS of -32.42 yen, the payout ratio calculates to negative (dividends paid against losses), though management maintains the dividend policy supported by positive free cash flow of 1.8B yen in Q3 cumulative period. Assuming approximately 8.2 million shares outstanding (after treasury shares), annual dividend outlay would approximate 0.4B yen, representing 22.9% of trailing twelve-month free cash flow, indicating sustainable coverage from cash generation despite accounting losses. Share repurchases recorded minimal activity of 0.0B yen in the period, resulting in total shareholder return effectively equal to dividend yield. The company's decision to maintain dividends at 5 yen despite negative earnings signals management confidence in underlying cash generation capability and commitment to shareholder returns, though elevated leverage (net debt to EBITDA of 11.6x) and interest coverage concerns suggest this policy could face pressure if operating performance fails to improve or debt refinancing becomes challenged. Dividend coverage by free cash flow of 4.5x (1.8B yen FCF versus estimated 0.4B yen dividend outlay) provides adequate buffer for near-term sustainability, but multi-year continuation would depend on return to profitability and deleveraging progress.
Single segment concentration in crystal products business exposes the company to cyclical demand shocks and pricing pressure without diversification buffer. Revenue of 41.8B yen derives entirely from crystal products segment, creating vulnerability to technology substitution, customer concentration, or end-market downturns in electronics and telecommunications sectors. Working capital deterioration with DSO of 99 days (exceeding industry median of 85 days), DIO of 219 days (nearly double industry median of 112 days), and cash conversion cycle of 290 days indicates operating inefficiency and potential inventory obsolescence risk. Extended working capital cycle ties up 20.2B yen in inventories (raw materials 10.7B yen, work-in-process 6.6B yen, finished goods 2.9B yen) and 11.3B yen in receivables, constraining cash availability and requiring continued borrowing support. Elevated financial leverage with net debt to EBITDA of 11.6x and negative interest coverage of -3.74x presents acute refinancing and solvency risk. Interest-bearing debt of 34.1B yen carries interest expense of 0.4B yen annually (implied interest rate 1.2%), while operating loss of -1.6B yen leaves no buffer for interest coverage. Short-term borrowings increased 61% YoY to 6.5B yen, indicating potential rollover of maturing long-term debt into shorter-duration facilities, which increases refinancing frequency and interest rate sensitivity. With cash of 30.0B yen covering only 88% of total debt and EBITDA of 3.0B yen providing limited deleveraging capacity, the company faces potential covenant pressure or need for asset monetization if profitability fails to recover, particularly given current operating losses and weak interest coverage metrics.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE -3.7% substantially underperforms manufacturing industry median of 5.8%, placing the company in the bottom quartile. Operating margin of -3.9% falls well below industry median of 8.9% and net profit margin of -3.9% versus industry median of 6.5%, indicating severe profitability challenges relative to peers. ROIC of -3.4% compares unfavorably to industry median of 6.0%.
Financial Health: Equity ratio of 41.4% sits below industry median of 63.8%, reflecting higher leverage positioning. Current ratio of 232.4% compares favorably to industry median of 287.0% though gap is moderate. Net debt to EBITDA of 11.6x dramatically exceeds industry median of -1.11x (net cash position), placing the company in the highest leverage decile of manufacturing peers and indicating distressed capital structure.
Efficiency: Asset turnover of 0.40x underperforms industry median of 0.56x, suggesting underutilization of asset base. Operating working capital turnover of 290 days (cash conversion cycle) substantially exceeds industry median of 112 days, highlighting severe working capital inefficiency. Inventory turnover of 219 days nearly doubles industry median of 112 days, indicating excess inventory or slow-moving stock issues. Receivables turnover of 99 days exceeds industry median of 85 days, suggesting collection challenges.
Growth: Revenue growth of 3.6% YoY outpaces industry median of 2.8%, representing one of the few positive relative metrics. However, EPS growth YoY deteriorated significantly versus industry median improvement of 9%.
Cash Generation: FCF yield comparison unavailable due to private company status. Cash conversion ratio (operating CF to net income) cannot be meaningfully compared given negative earnings, though positive operating CF of 3.2B yen demonstrates cash generation capability absent from many loss-making peers.
(Industry: Manufacturing sector, N=105 companies, Comparison: FY2025-Q3 benchmarks, Source: Proprietary analysis)
The company's positioning reflects bottom-quartile profitability, elevated leverage far exceeding industry norms, and severe working capital inefficiency, partially offset by adequate liquidity and modest revenue growth. The combination of operating losses, negative interest coverage, and net debt to EBITDA of 11.6x versus industry median net cash position represents the most critical competitive disadvantage requiring urgent management attention.
Key Takeaways from Earnings:
Structural profitability challenge requires operational restructuring as operating losses persist despite revenue growth, with SG&A expenses of 9.9B yen (23.6% of revenue) exceeding gross profit of 8.2B yen and creating a structural deficit. The company achieved EBITDA of 3.0B yen (7.1% margin) indicating positive cash earnings before interest and taxes, but must reduce SG&A burden by approximately 1.5-2.0B yen annually to reach breakeven operating profitability at current revenue levels. Working capital inefficiency represents a significant cash unlock opportunity, with inventory of 20.2B yen cycling at 219 days versus industry median of 112 days, suggesting potential release of 10B yen+ in trapped working capital through inventory rationalization and receivables acceleration. Achieving industry-median working capital efficiency would meaningfully reduce borrowing requirements and improve cash generation capacity without requiring revenue growth.
Financial leverage and debt maturity profile warrant immediate attention, as net debt to EBITDA of 11.6x with negative interest coverage and 61% increase in short-term borrowings to 6.5B yen indicate refinancing pressure and potential covenant risk. The company maintains adequate liquidity with 30.0B yen cash covering short-term obligations 4.65x, but elevated total debt of 34.1B yen against annual EBITDA of 3.0B yen (annualized from Q3 run rate) provides minimal natural deleveraging capacity. Management must prioritize debt reduction through either sustained free cash flow generation via working capital release, asset monetization as evidenced by 2.1B yen asset sale gains in Q3, or potential equity injection to restore financial stability and reduce interest burden of 0.4B yen that consumes all operating cash generation.
Dividend maintenance at 5 yen per share despite negative earnings signals management confidence in cash generation sustainability, with FCF of 1.8B yen covering estimated annual dividend outlay of 0.4B yen at 4.5x, though this policy sustainability depends on maintaining positive FCF and may face pressure if operating losses persist or refinancing challenges emerge. The combination of positive operating cash flow trends (+112.2% YoY), underinvestment concern (CapEx to depreciation of 0.59x), and reliance on extraordinary gains (2.1B yen asset sales) to support financial position suggests a company in transition, requiring execution on operational improvement to convert cash generation capability into sustainable profitability and gradual deleveraging over a multi-year horizon.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.